Levels of plasma fibrinogen and D-dimer in subjects with white-coat hypertension [1]

Journal of Human Hypertension

Volumn 18, Issue 4, 2004, Pages 291-292

  Çoban, Erkan ^a   Ozdogan M ^b   Akcit F ^c  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b Division of Oncology   (Turkey)

^c Department of Biochemistry ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN;

ADULT; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD RHEOLOGY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LETTER; MALE; SPHYGMOMANOMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; THROMBOGENESIS; WHITE COAT HYPERTENSION;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIASTOLE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYSTOLE;

EID: 7544227652     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001670     Document Type: Letter

References (11)

1. Pickering TG et al. Blood pressure monitoring. Task force V: White-coat hypertension. Blood Press Monit 1999; 4: 333-341.
2. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98: 1892-1897.
3. Palatini P et al. Target-organ damage in stage 1 hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31: 57-63.
4. Lip GY et al. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997; 80: 1566-1571.
5. Meade TW, Mellows S, Bozovic M. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
6. Smith FB et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-3325.
7. Sechi LA et al. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000; 36: 978-985.
8. Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis? Clin Sci 1995; 89: 205-214.
9. Chi DS et al. Coagulative and fibrinolytic changes in patients with essential hypertension and the effect on sustained-release nifedipine. Di Yi Jun Yi Da Xue Xue Bao 2002; 22: 168-170.
10. Vaziri ND et al. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. J Am Soc Nephrol 1993; 4: 222-228.
11. Pierdomenico SD et al. Twenty-four-hour autonomic nervous function in sustained and 'white coat' hypertension. Am Heart J 2000; 140: 672-677.